Search - tctmd.com

Displaying 321 - 340 of 343

Sort: Relevancy | Date

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

L.A. McKeown

August 05, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

Jason Kahn

July 25, 2011

News Daily News

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

July 25, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

After GRAVITAS: Is There a Future for Functional Platelet Testing?

July 18, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Daily News

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

May 31, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

L.A. McKeown

March 29, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

Sponsors Pull the Plug on TRIGGER-PCI

Jason Kahn

March 18, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Daily News

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

Jason Kahn

January 26, 2011

Advertisement

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Details on Clopidogrel Discontinuation Remain Elusive, Unclear

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Apixaban Increases Major Bleeding in High-Risk ACS Patients

After Gravitas Part 2: Is There a Future for Functional Platelet Testing?

Ticagrelor Gains FDA Approval for Use in ACS

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

After GRAVITAS: Is There a Future for Functional Platelet Testing?

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

Switching to Bivalirudin Effective After Early Heparin Therapy in STEMI Patients

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

ACC-AHA Release Guidelines Update on Unstable Angina-NSTEMI

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

Sponsors Pull the Plug on TRIGGER-PCI

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Prasugrel Inhibits Platelet Function Better Than High-Dose Clopidogrel in Diabetics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content